 James Finigan
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Lung Injury | 5 | 2012 | 268 | 1.430 |
Why?
| | Receptor, ErbB-2 | 5 | 2019 | 300 | 1.390 |
Why?
| | Neuregulin-1 | 5 | 2019 | 40 | 1.150 |
Why?
| | Respiratory Mucosa | 5 | 2018 | 251 | 1.030 |
Why?
| | Protein C | 4 | 2012 | 43 | 1.030 |
Why?
| | Lung | 8 | 2019 | 3521 | 0.650 |
Why?
| | Blood Coagulation Factors | 2 | 2012 | 43 | 0.640 |
Why?
| | Receptors, Cell Surface | 3 | 2012 | 350 | 0.630 |
Why?
| | Signal Transduction | 7 | 2019 | 4501 | 0.540 |
Why?
| | Cell Membrane Permeability | 1 | 2016 | 83 | 0.520 |
Why?
| | Lung Neoplasms | 5 | 2020 | 2159 | 0.510 |
Why?
| | ErbB Receptors | 3 | 2016 | 554 | 0.510 |
Why?
| | Adherens Junctions | 1 | 2014 | 26 | 0.470 |
Why?
| | Epithelial Cells | 2 | 2018 | 946 | 0.460 |
Why?
| | Cell Adhesion | 1 | 2014 | 426 | 0.420 |
Why?
| | beta Catenin | 1 | 2014 | 218 | 0.410 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2012 | 580 | 0.400 |
Why?
| | Capillary Permeability | 3 | 2010 | 137 | 0.400 |
Why?
| | Respiration, Artificial | 3 | 2012 | 528 | 0.370 |
Why?
| | Early Detection of Cancer | 1 | 2013 | 305 | 0.340 |
Why?
| | Permeability | 4 | 2015 | 149 | 0.330 |
Why?
| | Extravascular Lung Water | 1 | 2009 | 7 | 0.330 |
Why?
| | Smoking | 1 | 2016 | 1382 | 0.320 |
Why?
| | Electric Impedance | 3 | 2016 | 100 | 0.300 |
Why?
| | Transcriptional Activation | 2 | 2011 | 337 | 0.290 |
Why?
| | Glycoproteins | 1 | 2009 | 304 | 0.280 |
Why?
| | Blood Coagulation | 1 | 2008 | 200 | 0.280 |
Why?
| | Epithelium | 3 | 2019 | 295 | 0.270 |
Why?
| | Adenocarcinoma | 1 | 2012 | 787 | 0.260 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2005 | 12 | 0.240 |
Why?
| | Endothelium, Vascular | 2 | 2008 | 830 | 0.240 |
Why?
| | Interleukin-6 | 3 | 2019 | 673 | 0.230 |
Why?
| | Endothelium | 1 | 2005 | 109 | 0.230 |
Why?
| | Cell Line | 3 | 2016 | 2629 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2272 | 0.230 |
Why?
| | ADAM17 Protein | 2 | 2012 | 30 | 0.190 |
Why?
| | ADAM Proteins | 2 | 2012 | 58 | 0.190 |
Why?
| | Phosphorylation | 4 | 2019 | 1558 | 0.180 |
Why?
| | Hydroxychloroquine | 1 | 2020 | 54 | 0.180 |
Why?
| | Pulmonary Medicine | 1 | 2020 | 69 | 0.170 |
Why?
| | RNA, Small Interfering | 3 | 2014 | 534 | 0.170 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2020 | 77 | 0.160 |
Why?
| | Protein Kinase Inhibitors | 2 | 2014 | 784 | 0.160 |
Why?
| | Chemokine CCL11 | 1 | 2018 | 22 | 0.150 |
Why?
| | Animals | 10 | 2016 | 31565 | 0.150 |
Why?
| | Interleukin-13 | 1 | 2018 | 121 | 0.140 |
Why?
| | Tight Junctions | 2 | 2015 | 68 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 1 | 2018 | 93 | 0.140 |
Why?
| | Cell Adhesion Molecules | 1 | 2018 | 167 | 0.140 |
Why?
| | Critical Care | 1 | 2020 | 472 | 0.130 |
Why?
| | Humans | 20 | 2020 | 114043 | 0.130 |
Why?
| | Receptor, ErbB-3 | 1 | 2016 | 41 | 0.130 |
Why?
| | Quinazolines | 2 | 2014 | 240 | 0.130 |
Why?
| | Forced Expiratory Volume | 1 | 2017 | 471 | 0.130 |
Why?
| | Cluster Analysis | 1 | 2017 | 452 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 334 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2020 | 326 | 0.120 |
Why?
| | Sleep | 1 | 2020 | 631 | 0.120 |
Why?
| | Epidermal Growth Factor | 2 | 2012 | 160 | 0.120 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 959 | 0.120 |
Why?
| | Mice, Inbred C57BL | 2 | 2016 | 4680 | 0.110 |
Why?
| | Pulmonary Alveoli | 2 | 2015 | 372 | 0.110 |
Why?
| | RNA Interference | 1 | 2014 | 431 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2014 | 771 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1310 | 0.100 |
Why?
| | Radiography, Thoracic | 1 | 2013 | 150 | 0.100 |
Why?
| | History, 20th Century | 1 | 2013 | 265 | 0.100 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 140 | 0.100 |
Why?
| | Blood-Air Barrier | 1 | 2011 | 10 | 0.090 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2010 | 61 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 907 | 0.080 |
Why?
| | Stress, Mechanical | 2 | 2009 | 445 | 0.080 |
Why?
| | Myosin Light Chains | 2 | 2010 | 26 | 0.080 |
Why?
| | Endothelial Protein C Receptor | 1 | 2009 | 5 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2009 | 742 | 0.080 |
Why?
| | Capillaries | 1 | 2009 | 90 | 0.080 |
Why?
| | Pulmonary Edema | 1 | 2009 | 109 | 0.080 |
Why?
| | Thrombin | 2 | 2010 | 129 | 0.080 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 271 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2011 | 368 | 0.080 |
Why?
| | rho-Associated Kinases | 1 | 2009 | 80 | 0.080 |
Why?
| | Thromboplastin | 1 | 2008 | 69 | 0.080 |
Why?
| | Middle Aged | 4 | 2020 | 26605 | 0.070 |
Why?
| | Gene Expression | 2 | 2010 | 1417 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2018 | 3861 | 0.070 |
Why?
| | Transfection | 2 | 2010 | 863 | 0.070 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 407 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1204 | 0.070 |
Why?
| | Protein Binding | 2 | 2019 | 1888 | 0.070 |
Why?
| | Mice | 4 | 2011 | 14841 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1356 | 0.070 |
Why?
| | Female | 5 | 2020 | 59325 | 0.060 |
Why?
| | Male | 5 | 2020 | 55396 | 0.060 |
Why?
| | Endothelial Cells | 1 | 2010 | 677 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2012 | 3003 | 0.060 |
Why?
| | rac GTP-Binding Proteins | 1 | 2005 | 33 | 0.060 |
Why?
| | Threonine | 1 | 2005 | 40 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2005 | 93 | 0.060 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2005 | 55 | 0.060 |
Why?
| | Immunoprecipitation | 1 | 2005 | 151 | 0.060 |
Why?
| | Polymorphism, Genetic | 2 | 2005 | 610 | 0.060 |
Why?
| | Serine | 1 | 2005 | 125 | 0.060 |
Why?
| | Cytoskeleton | 1 | 2005 | 176 | 0.060 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 393 | 0.050 |
Why?
| | Actins | 1 | 2005 | 376 | 0.050 |
Why?
| | Sepsis | 2 | 2005 | 507 | 0.050 |
Why?
| | Biomarkers | 1 | 2012 | 3397 | 0.050 |
Why?
| | Inflammation | 1 | 2012 | 2464 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2011 | 3498 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1836 | 0.040 |
Why?
| | Aged | 2 | 2020 | 18969 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2019 | 2698 | 0.040 |
Why?
| | Etoposide | 1 | 2020 | 149 | 0.040 |
Why?
| | Adult | 3 | 2020 | 30375 | 0.040 |
Why?
| | Treatment Failure | 1 | 2020 | 330 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2005 | 2090 | 0.040 |
Why?
| | Advisory Committees | 1 | 2020 | 207 | 0.040 |
Why?
| | Critical Illness | 1 | 2004 | 640 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2019 | 34 | 0.040 |
Why?
| | Sirolimus | 1 | 2020 | 181 | 0.040 |
Why?
| | Cisplatin | 1 | 2020 | 262 | 0.040 |
Why?
| | Consensus | 1 | 2020 | 532 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1611 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 695 | 0.040 |
Why?
| | Betacoronavirus | 1 | 2020 | 247 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 359 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2018 | 148 | 0.040 |
Why?
| | Societies, Medical | 1 | 2020 | 655 | 0.030 |
Why?
| | United States | 3 | 2020 | 12137 | 0.030 |
Why?
| | Europe | 1 | 2017 | 332 | 0.030 |
Why?
| | Computational Biology | 2 | 2014 | 528 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 802 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6077 | 0.030 |
Why?
| | Aniline Compounds | 1 | 2014 | 70 | 0.030 |
Why?
| | Biological Transport | 1 | 2015 | 374 | 0.030 |
Why?
| | Nitriles | 1 | 2014 | 149 | 0.030 |
Why?
| | Quinolines | 1 | 2014 | 129 | 0.030 |
Why?
| | Mutation | 2 | 2014 | 3338 | 0.030 |
Why?
| | Protein Kinases | 1 | 2014 | 304 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2014 | 388 | 0.020 |
Why?
| | Tomography, Spiral Computed | 1 | 2011 | 23 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2011 | 180 | 0.020 |
Why?
| | Occludin | 1 | 2010 | 10 | 0.020 |
Why?
| | Bronchoscopy | 1 | 2011 | 196 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2764 | 0.020 |
Why?
| | Body Mass Index | 1 | 2017 | 1957 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2014 | 636 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 2784 | 0.020 |
Why?
| | Global Health | 1 | 2011 | 284 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2321 | 0.020 |
Why?
| | Hydrogen Peroxide | 1 | 2010 | 288 | 0.020 |
Why?
| | Occupational Exposure | 1 | 2011 | 255 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2011 | 1162 | 0.020 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1519 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1228 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1447 | 0.020 |
Why?
| | Nicotinamide Phosphoribosyltransferase | 1 | 2005 | 6 | 0.020 |
Why?
| | MEDLINE | 1 | 2004 | 22 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2010 | 1016 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2010 | 2562 | 0.010 |
Why?
| | Dogs | 1 | 2005 | 331 | 0.010 |
Why?
| | Databases, Genetic | 1 | 2004 | 206 | 0.010 |
Why?
| | Genetics, Population | 1 | 2004 | 187 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2010 | 2550 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17800 | 0.010 |
Why?
| | Genotype | 1 | 2005 | 1757 | 0.010 |
Why?
| | Cytokines | 1 | 2005 | 1824 | 0.010 |
Why?
| | Rats | 1 | 2005 | 4913 | 0.010 |
Why?
|
|
Finigan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|